These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 3969871

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
    Morady F, Sauve MJ, Malone P, Shen EN, Schwartz AB, Bhandari A, Keung E, Sung RJ, Scheinman MM.
    Am J Cardiol; 1983 Nov 01; 52(8):975-9. PubMed ID: 6637851
    [Abstract] [Full Text] [Related]

  • 4. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
    Raviele A, Di Pede F, Delise P, Piccolo E.
    G Ital Cardiol; 1984 Sep 01; 14(9):644-54. PubMed ID: 6510619
    [Abstract] [Full Text] [Related]

  • 5. Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation.
    Morady F, Scheinman MM, Hess DS.
    Pacing Clin Electrophysiol; 1983 May 01; 6(3 Pt 1):609-15. PubMed ID: 6191299
    [Abstract] [Full Text] [Related]

  • 6. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation.
    Herre JM, Sauve MJ, Malone P, Griffin JC, Helmy I, Langberg JJ, Goldberg H, Scheinman MM.
    J Am Coll Cardiol; 1989 Feb 01; 13(2):442-9. PubMed ID: 2913120
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease.
    Horowitz LN, Greenspan AM, Spielman SR, Webb CR, Morganroth J, Rotmensch H, Sokoloff NM, Rae AP, Segal BL, Kay HR.
    Am J Cardiol; 1985 Feb 01; 55(4):367-71. PubMed ID: 3969870
    [Abstract] [Full Text] [Related]

  • 8. Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone.
    Marchlinski FE, Buxton AE, Flores BT, Doherty JU, Waxman HL, Josephson ME.
    Am J Cardiol; 1985 Mar 01; 55(6):709-12. PubMed ID: 3976513
    [Abstract] [Full Text] [Related]

  • 9. Long-term follow-up of postmyocardial infarction patients with ventricular tachycardia or ventricular fibrillation treated with amiodarone.
    Strasberg B, Kusniec J, Zlotikamien B, Mager A, Sclarovsky S.
    Am J Cardiol; 1990 Sep 15; 66(7):673-8. PubMed ID: 2399883
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Management of refractory sustained ventricular tachycardia with amiodarone: a reappraisal.
    Lavery D, Saksena S.
    Am Heart J; 1987 Jan 15; 113(1):49-56. PubMed ID: 3799441
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ, Prystowsky EN, Zipes DP.
    Am Heart J; 1983 Oct 15; 106(4 Pt 2):887-94. PubMed ID: 6613835
    [Abstract] [Full Text] [Related]

  • 14. Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest.
    Morady F, Scheinman MM, Hess DS, Sung RJ, Shen E, Shapiro W.
    Am J Cardiol; 1983 Jan 01; 51(1):85-9. PubMed ID: 6849269
    [Abstract] [Full Text] [Related]

  • 15. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS, Fineberg N, Heger JJ, Miles WM, Kammerling JM, Chang MS, Zipes DP, Prystowsky EN.
    Am J Cardiol; 1988 May 01; 61(13):1024-30. PubMed ID: 3364357
    [Abstract] [Full Text] [Related]

  • 16. Failure of amiodarone to prevent ventricular fibrillation (sudden death) in hypertrophic cardiomyopathy.
    Mercereau D, Kubac G, Klinke WP.
    Can J Cardiol; 1989 Mar 01; 5(2):77-80. PubMed ID: 2706577
    [Abstract] [Full Text] [Related]

  • 17. Risk stratification and prognosis of patients treated with amiodarone for malignant ventricular tachyarrhythmias after myocardial infarction.
    Proclemer A, Facchin D, Vanuzzo D, Feruglio GA.
    Cardiovasc Drugs Ther; 1993 Aug 01; 7(4):683-9. PubMed ID: 8241012
    [Abstract] [Full Text] [Related]

  • 18. Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness.
    Flaker GC, Alpert MA, Webel RR, Ruder MA, Sanfelippo JF, Tsutakawa RK.
    Am Heart J; 1985 Aug 01; 110(2):371-6. PubMed ID: 4025112
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone.
    Manolis AS, Uricchio F, Estes NA.
    Am J Cardiol; 1989 May 01; 63(15):1052-7. PubMed ID: 2705375
    [Abstract] [Full Text] [Related]

  • 20. Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study.
    Naccarelli GV, Fineberg NS, Zipes DP, Heger JJ, Duncan G, Prystowsky EN.
    J Am Coll Cardiol; 1985 Oct 01; 6(4):814-21. PubMed ID: 3928727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.